{"url_path":"/sec/biaf/8-k/2026-06-30/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-30","source_url":"https://www.sec.gov/Archives/edgar/data/1712762/0001493152-26-031327-index.html","accession_number":"0001493152-26-031327","cik":"0001712762","ticker":"BIAF","issuer_name":"bioAffinity Technologies, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1712762/0001493152-26-031327-index.html","primary_entity_key":"0001712762","primary_entity_name":"bioAffinity Technologies, Inc."},"word_count":300,"has_tables":true,"body_markdown":"**Item\n8.01. Other Events.**\n\n \n\nOn\nJune 30, 2026, bioAffinity Technologies, Inc., a Delaware corporation (the “Company”), released a newsletter providing an\noverview of certain recent developments. A copy of the newsletter is attached hereto as Exhibit 99.1 and is incorporated herein by reference.\n\n \n\n*Forward-Looking\nStatements*\n\n \n\nCertain\nstatements in the newsletter constitute “forward-looking statements” within the meaning of the federal securities laws. Words\nsuch as “may,” “might,” “will,” “should,” “believe,” “expect,”\n“anticipate,” “estimate,” “continue,” “predict,” “forecast,” “project,”\n“plan,” “intend” or similar expressions, or statements regarding intent, belief, or current expectations, are\nforward-looking statements. These forward-looking statements are subject to various risks and uncertainties, many of which are difficult\nto predict, that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied\nby any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations include,\namong others, the Company’s ability to successfully commercialize CyPath® Lung, risks related to the regulatory\nenvironment for laboratory developed tests, and the other factors discussed in the Company’s Annual Report on Form 10-K for the\nyear ended December 31, 2025, and its subsequent filings with the Securities and Exchange Commission, including subsequent periodic reports\non Forms 10-Q and 8-K. Such forward-looking statements are based on facts and conditions as they exist at the time such statements are\nmade and predictions as to future facts and conditions. While the Company believes these forward-looking statements are reasonable, readers\nof the newsletter are cautioned not to place undue reliance on any forward-looking statements. The information in the newsletter are\nprovided only as of the date of the newsletter, and the Company does not undertake any obligation to update any forward-looking statement\nrelating to matters discussed in the newsletter, except as may be required by applicable securities laws."}